Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel ARMC5 Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing. | Diagnostics (Basel) | 2022 | 36553033 | PubTator, text mining | PubMed |
| Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells. | Cancers (Basel) | 2022 | 36551699 | PubTator, text mining | PubMed |
| Whole Genome Sequencing (WGS) Analysis of Virulence and AMR Genes in Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli from Animal and Environmental Samples in Four Italian Swine Farms. | Antibiotics (Basel) | 2022 | 36551431 | PubTator, text mining | PubMed |
| Mitochondrial Non-Coding RNAs Are Potential Mediators of Mitochondrial Homeostasis. | Biomolecules | 2022 | 36551291 | PubTator, text mining | PubMed |
| The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development. | Mol Biomed | 2022 | 36547804 | PubTator, text mining | PubMed |
| STXBP3 and GOT2 predict immunological activity in acute allograft rejection. | Front Immunol | 2022 | 36532048 | PubTator, text mining | PubMed |
| Synthetic lethal gene pairs: Experimental approaches and predictive models. | Front Genet | 2022 | 36531238 | PubTator, text mining | PubMed |
| Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma. | Front Oncol | 2022 | 36531056 | PubTator, text mining | PubMed |
| Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy. | Cancers (Basel) | 2022 | 36497394 | PubTator, text mining | PubMed |
| Correlation of photoreceptor damage with anti-retina antibodies level in aqueous humor in macular edema patients. | Sci Rep | 2022 | 36481862 | PubTator, text mining | PubMed |
| Leiomyoma with Bizarre Nuclei: A Current Update. | Int J Womens Health | 2022 | 36457718 | PubTator, text mining | PubMed |
| Multiple piloleiomyomas: a case series with dermoscopic features and a literature review. | Postepy Dermatol Alergol | 2022 | 36457688 | PubTator, text mining | PubMed |
| Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP). | PLoS One | 2022 | 36455002 | PubTator, text mining | PubMed |
| Hereditary Leiomyomatosis and Renal Cell Carcinoma: A Case Report and Review of the Literature. | Cureus | 2022 | 36451646 | PubTator, text mining | PubMed |
| Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy. | Cureus | 2022 | 36451642 | PubTator, text mining | PubMed |
| Editorial for November/December Issue of AACE Clinical Case Reports. | AACE Clin Case Rep | 2022 | 36447834 | PubTator, text mining | PubMed |
| Recurrent Cushing Syndrome From Metastatic Adrenocortical Carcinoma With Fumarate Hydratase Allelic Variant. | AACE Clin Case Rep | 2022 | 36447829 | PubTator, text mining | PubMed |
| DNA Methylation and Epigenetic Events Underlying Renal Cell Carcinomas. | Cureus | 2022 | 36447689 | PubTator, text mining | PubMed |
| Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma. | J Hematol Oncol | 2022 | 36434634 | PubTator, text mining | PubMed |
| Biomechanical Forces Determine Fibroid Stem Cell Transformation and the Receptivity Status of the Endometrium: A Critical Appraisal. | Int J Mol Sci | 2022 | 36430682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=29